Article

ForbesForbes on 2017-03-28 18:00

Regeneron's New Drug Price Could Disappoint Everyone. Here's Why That's A Good Thing

Regeneron's billionaire chief executive Leonard Schleifer has said that the drug industry's pricing is "ridiculous." So when his own new drug, ...

Related news